Barclays’s American Oncology Network, Inc. Class A Common Stock AONC Stock Holding History

Barclays’s Portfolio AONC Stock Details AONC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-38	Closed	-$224	–	5440
2023 Q4	$224	Buy	+38	New	+$246	﹤0.01%	5152
2022 Q4	–	Sell	-44,321	Closed	-$435K	–	5421
2022 Q3	$435K	Hold	44,321	–	–	﹤0.01%	2784
2022 Q2	$433K	Hold	44,321	–	–	﹤0.01%	2974
2022 Q1	$433K	Buy	+44,321	New	+$431K	﹤0.01%	2996

Other funds holding AONC

Applied Capital Little Rock, Arkansas $310M AUM 19.94% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BIP Wealth Atlanta, Georgia $2.46B AUM 14.38% 1-Year Est. Return

TSS

Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

CFFP

Center for Financial Planning Southfied, Michigan $1.07B AUM 18.98% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Barclays's AONC Position: Q1 2024 in Review

Barclays sold out of American Oncology Network, Inc. Class A Common Stock (AONC) in Q1 2024, closing a stake of 38 shares — an estimated $224 sold.

Barclays first reported a position in AONC in Q1 2022 and held it in 4 quarters. The position peaked at $435K in Q3 2022. 10 funds tracked by Wall St. Rank hold AONC as of Q1 2024.

Barclays reported no remaining American Oncology Network, Inc. Class A Common Stock position as of Q1 2024 after selling out during the quarter.
Barclays sold 38 American Oncology Network, Inc. Class A Common Stock shares in Q1 2024, an estimated $224.
Barclays first reported a position in American Oncology Network, Inc. Class A Common Stock in Q1 2022 and held it in 4 quarters.
Barclays's American Oncology Network, Inc. Class A Common Stock position peaked at $435K in Q3 2022.
10 funds tracked by Wall St. Rank held American Oncology Network, Inc. Class A Common Stock as of Q1 2024.

Based on Barclays's 13F filing for Q1 2024, filed 15 May 2024.